Argus lowered the firm’s price target on Alcon to $90 from $95 but keeps a Buy rating on the shares. The firm retains a favorable view of the company’s market position and product pipeline, while noting that its sales growth has outpaced increases in marketing and selling costs, resulting in higher margins, the analyst tells investors in a research note. The stock is down sharply since early September 2023, but Alcon has a history of achieving substantial gains after similar periods of losses, the firm adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALC:
- Alcon downgraded at Morgan Stanley on changing patient pool for cataract surgery
- Alcon downgraded to Underweight from Equal Weight at Morgan Stanley
- Alcon price target lowered to $88 from $94 at Jefferies
- Alcon price target lowered to CHF 74.40 from CHF 78.60 at JPMorgan
- Alcon price target lowered to $86 from $98 at Needham